Venus Remedies Limited (BOM:526953)

Venus Remedies Statistics

Total Valuation

Venus Remedies has a market cap or net worth of INR 9.71 billion. The enterprise value is 7.50 billion.

Market Cap	9.71B
Enterprise Value	7.50B

Important Dates

The next estimated earnings date is Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Venus Remedies has 13.37 million shares outstanding. The number of shares has decreased by -0.17% in one year.

Current Share Class	13.37M
Shares Outstanding	13.37M
Shares Change (YoY)	-0.17%
Shares Change (QoQ)	-0.03%
Owned by Insiders (%)	30.05%
Owned by Institutions (%)	1.10%
Float	6.37M

Valuation Ratios

The trailing PE ratio is 13.80.

PE Ratio	13.80
Forward PE	n/a
PS Ratio	1.39
PB Ratio	1.63
P/TBV Ratio	1.96
P/FCF Ratio	7.93
P/OCF Ratio	6.84
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.72, with an EV/FCF ratio of 6.12.

EV / Earnings	10.66
EV / Sales	1.07
EV / EBITDA	7.72
EV / EBIT	9.67
EV / FCF	6.12

Financial Position

The company has a current ratio of 3.40, with a Debt / Equity ratio of 0.02.

Current Ratio	3.40
Quick Ratio	2.39
Debt / Equity	0.02
Debt / EBITDA	0.15
Debt / FCF	0.12
Interest Coverage	1,708.04

Financial Efficiency

Return on equity (ROE) is 12.92% and return on invested capital (ROIC) is 8.47%.

Return on Equity (ROE)	12.92%
Return on Assets (ROA)	6.79%
Return on Invested Capital (ROIC)	8.47%
Return on Capital Employed (ROCE)	12.41%
Weighted Average Cost of Capital (WACC)	5.93%
Revenue Per Employee	5.39M
Profits Per Employee	541,639
Employee Count	1,298
Asset Turnover	0.98
Inventory Turnover	3.50

Taxes

In the past 12 months, Venus Remedies has paid 246.92 million in taxes.

Income Tax	246.92M
Effective Tax Rate	25.99%

Stock Price Statistics

The stock price has increased by +144.36% in the last 52 weeks. The beta is 0.32, so Venus Remedies's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	+144.36%
50-Day Moving Average	731.86
200-Day Moving Average	506.24
Relative Strength Index (RSI)	50.61
Average Volume (20 Days)	1,701

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Venus Remedies had revenue of INR 6.99 billion and earned 703.05 million in profits. Earnings per share was 52.64.

Revenue	6.99B
Gross Profit	3.03B
Operating Income	775.45M
Pretax Income	949.97M
Net Income	703.05M
EBITDA	971.11M
EBIT	775.45M
Earnings Per Share (EPS)	52.64

Balance Sheet

The company has 2.36 billion in cash and 143.80 million in debt, with a net cash position of 2.21 billion or 165.61 per share.

Cash & Cash Equivalents	2.36B
Total Debt	143.80M
Net Cash	2.21B
Net Cash Per Share	165.61
Equity (Book Value)	5.94B
Book Value Per Share	444.63
Working Capital	3.43B

Cash Flow

In the last 12 months, operating cash flow was 1.42 billion and capital expenditures -194.97 million, giving a free cash flow of 1.22 billion.

Operating Cash Flow	1.42B
Capital Expenditures	-194.97M
Free Cash Flow	1.22B
FCF Per Share	91.61

Margins

Gross margin is 43.33%, with operating and profit margins of 11.09% and 10.06%.

Gross Margin	43.33%
Operating Margin	11.09%
Pretax Margin	13.59%
Profit Margin	10.06%
EBITDA Margin	13.89%
EBIT Margin	11.09%
FCF Margin	17.52%

Dividends & Yields

Venus Remedies does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.17%
Shareholder Yield	0.17%
Earnings Yield	7.24%
FCF Yield	12.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6